Expression of survivin, PTEN and p27 in normal, hyperplastic, and carcinomatous endometrium
- 1 May 2006
- journal article
- Published by Elsevier in International Journal of Gynecologic Cancer
- Vol. 16 (3) , 1412-1418
- https://doi.org/10.1111/j.1525-1438.2006.00541.x
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Risk of progression in complex and atypical endometrial hyperplasia: clinicopathologic analysis in cases with and without progestogen treatmentInternational Journal of Gynecologic Cancer, 2004
- The Role of p27 in Endometrial CarcinomaGynecologic Oncology, 2001
- Survivin promotes cell proliferation in human hepatocellular carcinomaHepatology, 2000
- ThePTEN, BAX,andIGFIIRGenes Are Mutated in Endometrial Atypical HyperplasiaJapanese Journal of Cancer Research, 1998
- High level expression of p27 kip1 and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27 kip1 and degree of malignancy in human breast and colorectal cancersProceedings of the National Academy of Sciences, 1997
- A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cellsOncogene, 1997
- The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cellsOncogene, 1997
- Genetic Alterations of Cyclins, Cyclin-Dependent Kinases, and Cdk Inhibitors in Human CancerAdvances in Cancer Research, 1996
- Inhibitors of mammalian G1 cyclin-dependent kinases.Genes & Development, 1995
- Cyclins and cancer II: Cyclin D and CDK inhibitors come of ageCell, 1994